Hans-Tilman Kinkel

Suggest Changes
Learn More
BACKGROUND Relaxin-2, a candidate drug for acute heart failure, has been tested successfully in the first human trials. We investigated relaxin's inotropic effects in human myocardium. METHODS AND(More)
  • 1